onjcri

Study advances gene-editing capabilities for cancer and medical research through genetic manipulations using Cas12a enzyme Australian cancer researchers have been the first to establish a novel gene-editing tool for modelling and interrogating human disease. A pre-clinical model expressing an enhanced version of a new genome-engineering enzyme called Cas12a was generated by researchers at the Olivia … Read more